Effects of Probiotics on Serum Bilirubin Levels of newborns.
Phase 2
- Registration Number
- CTRI/2024/05/066726
- Lead Sponsor
- Jawaharlal Nehru Medical College, KLE University Belagavi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newborns born after 35 weeks of gestation from day 3 of life to day 6 of life
Exclusion Criteria
Neonate of a gestational diabetic mother.
Familial hematological disorder with signs of hemolysis.
Neonates requiring intensive care admission during first 3 days of life.
Neonates with congenital anomalies/malformations.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the role of lactobacillus rhamnosus gg in reducing serum bilirubin levels in neonates.Timepoint: To assess the role of lactobacillus rhamnosus gg in reducing serum bilirubin levels in neonates over a period of first 5 days of life.
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil